切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2015, Vol. 09 ›› Issue (06) : 431 -436. doi: 10.3877/cma.j.issn.1674-0793.2015.06.005

所属专题: 文献

论著

丙型肝炎病毒核心蛋白通过活化stat3通路促进肝癌细胞上皮间质转化的研究
周嘉嘉1, 陈汝福1,(), 邓小耿1, 高文超1, 郑上游1, 程帝1, 周泉波1, 张杰1   
  1. 1. 510120 广州,中山大学孙逸仙纪念医院外科
  • 收稿日期:2015-09-07 出版日期:2015-12-01
  • 通信作者: 陈汝福
  • 基金资助:
    国家自然科学基金青年基金项目(81000889); 广东省自然科学基金重点资助项目(2014A030311047); 广东省科技计划项目(2014A020212094)

Hepatitis C virus core protein activating stat3 pathway and promoting epithelial-mesenchymal transition in hepatocellular cells

Jiajia Zhou1, Rufu Chen1,(), Xiaogeng Deng1, Wenchao Gao1, Shangyou Zheng1, Di Cheng1, Quanbo Zhou1, Jie Zhang1   

  1. 1. Department of Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China
  • Received:2015-09-07 Published:2015-12-01
  • Corresponding author: Rufu Chen
  • About author:
    Corresponding author: Chen Rufu, Email:
引用本文:

周嘉嘉, 陈汝福, 邓小耿, 高文超, 郑上游, 程帝, 周泉波, 张杰. 丙型肝炎病毒核心蛋白通过活化stat3通路促进肝癌细胞上皮间质转化的研究[J/OL]. 中华普通外科学文献(电子版), 2015, 09(06): 431-436.

Jiajia Zhou, Rufu Chen, Xiaogeng Deng, Wenchao Gao, Shangyou Zheng, Di Cheng, Quanbo Zhou, Jie Zhang. Hepatitis C virus core protein activating stat3 pathway and promoting epithelial-mesenchymal transition in hepatocellular cells[J/OL]. Chinese Archives of General Surgery(Electronic Edition), 2015, 09(06): 431-436.

目的

探讨丙型肝炎病毒核心蛋白(HCVc)对肝癌细胞信号转导子和转录激活子3(stat3)通路及上皮间质转化(EMT)的影响。

方法

将含HCVc基因序列的重组质粒pEGFP-N3-HCVc转染人肝癌细胞HepG2,Real-Time PCR和Western blotting检测HCVc、总stat3、磷酸化stat3(p-stat3)及EMT指标蛋白E-cadherin、Vimentin、Snail的表达,划痕实验及Transwell实验检测细胞迁移和侵袭情况。

结果

划痕实验及Transwell实验结果显示,过表达HCVc可增强HepG2细胞的迁移和侵袭能力;stat3通路抑制剂AG490处理可抑制HepG2细胞的侵袭能力。RT-PCR和Western blotting结果显示,过表达HCVc后,HepG2细胞中p-stat3、Vimentin及Snail在表达升高,E-cadherin表达下降;AG490处理可下调p-stat3、Vimentin及Snail表达,增强E-cadherin表达。

结论

HCVc可活化stat3通路促进肝癌细胞上皮间质转化,增强肝癌细胞的迁移和侵袭能力。

Objective

To investigate the role of hepatitis C virus core protein (HCVc) on the activation of stat3 pathway and regulation of epithelial-mesenchymal transition in hepatocellular cells, which might be involved in tumor metastasis of liver cancer.

Methods

Recombinant plasmid pEGFP-N3-HCVc containing HCVc gene was transfected to over-expressed HCVc in HepG2 cells. Real-Time PCR and Western blotting were used to detect the expression of HCVc, stat3, phosphorylated stat3 (p-stat3), E-cadherin, Vimentin and Snail. Wound healing test and Transwell assay was employed to detect cell migration and invasiveness.

Results

Wound healing test and Transwell assay showed that over-expression of HCVc in HepG2 cells promoted the cell migration and invasiveness. Meanwhile, AG490 treatment inhibited cell migration and invasiveness of HCVc over-expressing cells. RT-PCR and Western blotting analysis showed that expression of HCVc, p-stat3, Vimentin and Snail were increased and E-cadherin was decreased in HCVc over-expressing HepG2 cells. Treatment of AG490 on HCVc over-expressing cells could attenuate HCVc-induced up-regulation of p-stat3, Vimentin and Snail expression and down-regulation of E-cadherin.

Conclusion

HCVc activates stat3 pathway and promotes epithelial-mesenchymal transition in HepG2 cells, which may be associated with enhanced cell migration and invasion in liver cancer.

图1 Western blotting检测肝癌细胞HepG2-HCVc中HCVc蛋白的表达
图2 划痕试验检测转染HCVc后肝癌细胞HepG2-HCVc的迁移能力
图3 Transwell侵袭实验检测转染HCVc后肝癌细胞HepG2-HCVc的侵袭能力(200×),左图为HepG2-Vector细胞穿过基底膜情况,中图为HepG-HCVc细胞穿过基底膜情况,右图为两组细胞侵袭细胞数对比
图4 Real-Time PCR(A)和Western Blotting(B)检测HepG2-HCVc细胞中E-cadherin、Vimentin及Snail mRNA和蛋白的表达
图5 Western Blotting检测HepG2-HCVc细胞中总stat3和p-stat3蛋白的表达
图6 Western Blotting检测AG490处理后HepG2-HCVc细胞中总stat3和p-stat3蛋白的表达
图7 Transwell侵袭实验检测AG490处理后HepG2-HCVc细胞的侵袭能力
图8 Real-Time PCR(A)和Western Blotting(B)检测AG490处理后HepG2-HCVc细胞中E-cadherin、Vimentin及Snail mRNA和蛋白的表达
1
Arzumanyan A, Reis HM, Feitelson MA. Pathogenic mechanisms in HBV- and HCV- associated hepatocellular carcinoma[J]. Nat Rev Cancer, 2013, 13(2):123-135.
2
Moriya K, Fujie H, Shintani Y, et al. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice[J]. Nat Med, 1998, 4(9): 1065-1067.
3
Park J, Kang W, Ryu SW, et al. Hepatitis C virus infection enhances TNFα-induced cell death via suppression of NF-κB[J]. Hepatology, 2012, 56(3): 831-840.
4
Reichl P, Haider C, Grubinger M, et al. TGF-β in epithelial to mesenchymal transition and metastasis of liver carcinoma[J]. Curr Pharm Des, 2012, 18(27): 4135-4147.
5
Demaria M, Misale S, Giorgi C, et al. STAT3 can serve as a hit in the process of malignant transformation of primary cells[J]. Cell Death Differ, 2012, 19(8): 1390-1397.
6
唐晶, 周嘉嘉, 邓小耿, 等. 丙型肝炎病毒核心蛋白对肝癌细胞stat3通路及细胞周期蛋白cyclin D1的调控作用[J]. 中山大学学报(医学科学版), 2013, 34(4): 498-504.
7
Rokavec M, Öner MG, Li H, et al. IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis[J]. J Clin Invest, 2014, 124(4): 1853-1867.
8
Liu H, Ren G, Wang T, et al. Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition[J]. Carcinogenesis, 2015, 36(4): 459-468.
9
Liu L, Dai Y, Chen J, et al. Maelstrom promotes hepatocellular carcinoma metastasis by inducing epithelial-mesenchymal transition by way of Akt/GSK-3β/Snail signaling[J]. Hepatology, 2014, 59(2): 531-543.
10
Zhu M, Yin F, Fan X, et al. Decreased TIP30 promotes Snail-mediated epithelial-mesenchymal transition and tumor-initiating properties in hepatocellular carcinoma[J]. Oncogene, 2015, 34(11): 1420-1431.
11
Wang Z, Li Y, Sarkar FH. Signaling mechanism(s) of reactive oxygen species in Epithelial-Mesenchymal Transition reminiscent of cancer stem cells in tumor progression[J]. Curr Stem Cell Res Ther, 2010, 5(1): 74-80.
12
Zhou W, Lv R, Qi W, et al. Snail contributes to the maintenance of stem cell-like phenotype cells in human pancreatic cancer[J]. PLoS One, 2014, 9(1): e87409.
13
Masui T, Ota I, Yook JI, et al. Snail-induced epithelial-mesenchymal transition promotes cancer stem cell-like phenotype in head and neck cancer cells[J]. Int J Oncol, 2014, 44(3): 693-699.
14
程志祥, 汪谦. 干细胞与肝癌干细胞相关研究进展[J/CD]. 中华普通外科学文献:电子版, 2010, 4(5): 491-494.
15
Ali N, Allam H, May R, et al. Hepatitis C virus-induced cancer stem cell-like signatures in cell culture and murine tumor xenografts[J]. J Virol, 2011, 85(23): 12292-12303.
16
Iliopoulos D, Hirsch HA, Wang G, et al. Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion[J]. Proc Natl Acad Sci U S A, 2011, 108(4): 1397-1402.
17
Marotta LL, Almendro V, Marusyk A, et al. The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24- stem cell-like breast cancer cells in human tumors[J]. J Clin Invest, 2011, 121(7): 2723-2735.
[1] 刘莉莉, 贾建茹, 张晶, 周大琼, 刘江雨, 曹振环. 单纯慢性乙型肝炎患者与慢性乙型肝炎合并肝脂肪变患者的临床特征横断面研究[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(05): 270-277.
[2] 高俊颖, 张海洲, 区泓乐, 孙强. FOLFOX-HAIC 为基础的肝细胞癌辅助转化治疗的应用进展[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 457-463.
[3] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[4] 赖全友, 高远, 汪建林, 屈士斌, 魏丹, 彭伟. 三维重建技术结合腹腔镜精准肝切除术对肝癌患者术后CD4+、CD8+及免疫球蛋白水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 651-654.
[5] 李一帆, 朱帝文, 任伟新, 鲍应军, 顾俊鹏, 张海潇, 曹耿飞, 阿斯哈尔·哈斯木, 纪卫政. 血GP73水平在原发性肝癌TACE疗效评价中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 825-830.
[6] 刘敏思, 李荣, 李媚. 基于GGT与Plt比值的模型在HBV相关肝细胞癌诊断中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 831-835.
[7] 陆镜明, 韩大为, 任耀星, 黄天笑, 向俊西, 张谞丰, 吕毅, 王傅民. 基于术前影像组学的肝内胆管细胞癌淋巴结转移预测的系统性分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 852-858.
[8] 吴雪云, 胡小军, 范应方. 肝切除术中剩余肝再生能力的评估与预测[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 894-897.
[9] 邓万玉, 陈富, 许磊波. 肝硬化与非肝硬化乙肝相关性肝癌患者术后无复发生存比较及其影响因素分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 670-674.
[10] 林小勇, 张兰霞, 曾庆劲, 贺需旗, 谭雷, 郭光辉, 龙颖琳, 李凯, 吴宇轩. 负压抽吸活检针在肝困难病灶活检中的初步应用研究[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 694-698.
[11] 雷永琪, 刘新阳, 杨黎渝, 铁学宏, 俞星新, 耿志达, 刘雨, 陈政良, 惠鹏, 梁英健. 肝脏血管周上皮样细胞肿瘤合并贫血一例并文献复习[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 710-718.
[12] 董佳, 王坤, 张莉. 预后营养指数结合免疫球蛋白、血糖及甲胎蛋白对HBV 相关慢加急性肝衰竭患者治疗后预后不良的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 555-559.
[13] 唐诗, 薛传优, 叶兴, 张鸿举, 戴瑞. 急性病毒性肝炎患者血脂、血糖、蛋白、尿酸变化特点及其与预后的关联[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 396-399.
[14] 黄圣楷, 许斌, 苏健, 孙龙. 海南省2010~2020年乙型肝炎流行趋势的时间序列分析及预测[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 555-561.
[15] 王星, 陈园, 热孜万古丽·乌斯曼, 郭艳英. T2DM、Obesity、NASH、PCOS共同致病因素相关的分子机制[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 481-490.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?